John W Rose

Analysis of proinflammatory and anti-inflammatory cytokine serum concentrations in patients with multiple sclerosis by using a multiplexed immunoassay.

T. Jaskowski, H. Hill, Harry R Hill, 2011, American journal of clinical pathology.

Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta

Xavier Montalban, James Sheridan, X. Montalban, 2010, The Lancet Neurology.